SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-128645
Filing Date
2021-10-21
Accepted
2021-10-21 20:50:57
Documents
1
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130646-14_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2130646-14_3seq1.xml 3 5135
  Complete submission text file 0001104659-21-128645.txt   6639
Mailing Address FRANKFURTER STR. 250 DARMSTADT 2M 64293
Business Address FRANKFURTER STR. 250 DARMSTADT 2M 64293 004961517245950
Merck KGaA (Reporting) CIK: 0001764133 (see all company filings)

State of Incorp.: 2M | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 211338457

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations